1. Lui GK, Saidi A, Bhatt AB, et al. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017; 136:e348–e392.
Article
2. Dimopoulos K, Diller GP, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008; 117:2320–2328.
Article
3. Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol. 2006; 21:1440–1445.
Article
4. Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010; 31:703–711.
Article
5. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999; 341:577–585.
Article
6. Magri P, Rao MA, Cangianiello S, et al. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation. 1998; 98:2849–2854.
Article
7. Taylor ML, Carmona F, Thiagarajan RR, et al. Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2013; 146:146–152.
Article
8. Collins RT 2nd. Cardiovascular disease in Williams syndrome. Circulation. 2013; 127:2125–2134.
Article
9. Hongsawong N, Khamdee P, Silvilairat S, Chartapisak W. Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease. Pediatr Nephrol. 2018; 33:493–501.
Article
10. Oka H, Nakau K, Kajihama A, Azuma H. Assessment of potential renal dysfunction in patients with congenital heart disease after biventricular repair. Korean Circ J. 2018; 48:418–426.
Article